ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,114,531 | -7.5% | 41,066 | +4.8% | 0.01% | 0.0% |
| Q2 2023 | $1,204,854 | -9.5% | 39,195 | +6.0% | 0.01% | -16.7% |
| Q1 2023 | $1,331,668 | -11.8% | 36,960 | -3.3% | 0.01% | -14.3% |
| Q4 2022 | $1,510,217 | -2.4% | 38,214 | -0.8% | 0.01% | -12.5% |
| Q3 2022 | $1,548,000 | 0.0% | 38,535 | +4.6% | 0.02% | +6.7% |
| Q2 2022 | $1,548,000 | +8.2% | 36,827 | +0.2% | 0.02% | +25.0% |
| Q1 2022 | $1,431,000 | +0.6% | 36,738 | +2.9% | 0.01% | +9.1% |
| Q4 2021 | $1,423,000 | +107.7% | 35,715 | +88.4% | 0.01% | +83.3% |
| Q3 2021 | $685,000 | -7.8% | 18,954 | +4.5% | 0.01% | -14.3% |
| Q2 2021 | $743,000 | -5.0% | 18,130 | +1.1% | 0.01% | -12.5% |
| Q1 2021 | $782,000 | +21.4% | 17,929 | +39.3% | 0.01% | -20.0% |
| Q4 2020 | $644,000 | – | 12,873 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |